An artificial photoenzyme shows high enantioselectivity in cycloadditions for bicyclo[2.1.1]hexanes, indicating new synthetic pathways.
Bicyclo[2.1.1]hexanes (BCHs) are valuable bioisosteres, yet efficient catalytic methods for their asymmetric construction remain limited. We report an artificial photoenzyme system that enables highly enantioselective intermolecular [2π+2σ] cycloadditions between quinolin-2(1H)-ones and monosubstituted bicyclobutanes (BCBs). Central to this platform is MeO-BpAD, a rationally designed photoactive NAD⁺ analogue that operates under 400 nm irradiation to suppress background reactivity while maintaining specific binding to NAD⁺-dependent proteins. In combination with an engineered Rr12αHSDH-M4 mutant, this artificial photoenzyme delivers chiral BCHs in moderate to high yields and up to 94% ee across a broad range of BCB substrates. Photophysical studies show that the protein scaffold stabilizes the MeO-BpAD excited state, whereas MD simulations and QM/MM calculations reveal the key exciplex intermediate and indicate that stereocontrol arises from defined noncovalent interactions within the active site. These results underscore the versatility of NAD⁺-analogue-based artificial photoenzymes in enabling stereocontrolled transformations that remain challenging for conventional methods.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: